Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 24;59(3):2102102.
doi: 10.1183/13993003.02102-2021. Print 2022 Mar.

In vivo microevolution of Mycobacterium tuberculosis and transient emergence of atpE _Ala63Pro mutation during treatment in a pre-XDR TB patient

Affiliations

In vivo microevolution of Mycobacterium tuberculosis and transient emergence of atpE _Ala63Pro mutation during treatment in a pre-XDR TB patient

Arash Ghodousi et al. Eur Respir J. .

Abstract

This letter describes microevolution of a pre-XDR MTB strain isolated from a pulmonary TB patient over an 18-month exposure to BDQ. MDR-TB therapies with BDQ require a functional background regimen to prevent emergence of additional resistance. https://bit.ly/3D05qT9

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

FIGURE 1
FIGURE 1
a) Shown is a summary of genotypic drug resistance (based on whole genome sequencing (WGS)). b) Bedaquiline minimum inhibitory concentrations (MICs) performed in 7H11 and MGIT, and treatment monitoring during the bedaquiline-containing regimen. c) Growth curves of standing liquid cultures of Mycobacterium tuberculosis strains including H37Rv, baseline isolates (isolate A) and mutant strains (isolates B and E). The experiment was repeated three times giving comparable results and the mean values were plotted. Bdq: bedaquiline; Mfx: moxifloxacin; Lzd: linezolid; Cfz: clofazimine; Cs: cycloserine: Cm: capreomycin; Dlm: delamanid; Eto: ethionamide; Z: pyrazinamide; XDR: extensively drug resistant.

Comment in

References

    1. World Health Organization . WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment. Geneva, World Health Organization, 2019. - PubMed
    1. World Health Organization . WHO Consolidated Guidelines on Tuberculosis. Geneva, World Health Organization, 2020.
    1. Ghodousi A, Rizvi AH, Baloch AQ, et al. Acquisition of cross-resistance to bedaquiline and clofazimine following treatment for tuberculosis in Pakistan. Antimicrob Agents Chemother 2019; 63: e00915-19. - PMC - PubMed
    1. World Health Organization . Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines used in the Treatment of Drug-resistant Tuberculosis. Geneva, World Health Organization, 2018.
    1. Peñuelas-Urquides K, Villarreal-Treviño L, Silva-Ramírez B,et al. Measuring of Mycobacterium tuberculosis growth. A correlation of the optical measurements with colony forming units. Braz J Microbiol 2013; 44: 287–289. doi: 10.1590/S1517-83822013000100042 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources